Back Pain News and Research

Latest Back Pain News and Research

Spinal Restoration: Success criteria not met for primary analysis of Phase III study of Biostat System

Spinal Restoration, Inc. announced today that the success criteria for primary analysis of the Phase III Investigational New Drug study of the Biostat System were not met. The proportions of successful patients that received BIOSTAT BIOLOGX Fibrin Sealant or saline injection were not statistically significantly different when analyzed at the 26-week primary endpoint.

19 Jul 2013

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Celgene Corporation today announced that after consultation with the U.S. Food and Drug Administration Celgene will discontinue treatment with REVLIMID (lenalidomide) in the open-label, phase III ORIGIN trial, which enrolled 450 patients in over 100 sites in 26 countries.

18 Jul 2013

Cell therapies may stop or reverse pain and disability of degenerative disc disease

Cell therapies may stop or reverse the pain and disability of degenerative disc disease and the loss of material between vertebrae, according to Duke University scientists.

17 Jul 2013

UC Riverside study finds that married men are less likely to die of HIV/AIDS

At the height of the AIDS epidemic in the 1980s men who were married were significantly less likely to die of HIV/AIDS than their divorced or otherwise single counterparts, according to a University of California, Riverside analysis of new mortality data for that era.

15 Jul 2013

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that its phase III study (MM-020/IFM 07-01) of REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma met its primary endpoint of progression-free survival.

11 Jul 2013

S.M. Rezaian says that the spine degrades following inadequate treatment

S.M. Rezaian, MD, FRCS, FICS, PhD has treated well over 13,000 patients throughout his illustrious career in orthopedic medicine. He's truly been an innovator in the field, creating the Rezaian Spinal Fixator and applying minimally-invasive laser back surgery both of which allow for more comprehensive and less risky surgical treatments.

6 Jul 2013

Weekly yoga class provides similar lower back pain relief as twice weekly classes for low-income patients

Researchers at Boston University School of Medicine and Boston Medical Center have found that a weekly yoga class provided similar lower back pain relief and reduced the need for pain medication as twice weekly classes in lower income minority patients.

3 Jul 2013

Eisai submits BELVIQ NDS with Health Canada

Arena Pharmaceuticals, Inc. announced today that Eisai Limited (based in Mississauga, Ontario), a subsidiary of Eisai Inc., has submitted a New Drug Submission for BELVIQ (lorcaserin HCl) with Health Canada.

26 Jun 2013

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.

24 Jun 2013

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., a pharmaceutical company strongly committed to the respiratory, primary care and CNS therapeutic areas, presented results from SETTLE Phase III study with safinamide at the 17th International Congress of Parkinson's disease and Movement Disorders, taking place from June 16 to 20, 2013, at the Sydney Convention and Exhibition Centre, Sydney, Australia.

19 Jun 2013

Spinal infection at contaminated drug injection site detected using contrast-enhanced MRI screening

Magnetic resonance imaging (MRI) at the site of injection of a contaminated lot of a steroid drug to treat symptoms such as back pain resulted in earlier identification of patients with probable or confirmed fungal spinal or paraspinal infection, allowing early initiation of medical and surgical treatment, according to a study in the June 19 issue of JAMA.

19 Jun 2013

European Commission amends marketing authorisation for Celgene's REVLIMID

Celgene International Sàrl was today notified that the European Commission has amended the marketing authorisation for REVLIMID. This decision means that REVLIMID is now approved to treat patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.

17 Jun 2013

Xgeva receives FDA approval for treating giant cell tumor of the bone

The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone, a rare and usually non-cancerous tumor.

14 Jun 2013

NACC recommendations address established pain therapies and preview potential future advances

Recommendations of the Neuromodulation Appropriateness Consensus Committee (NACC), announced at the 11th World Congress of the International Neuromodulation Society (INS), address established therapies and preview emerging and potential future advances.

13 Jun 2013

University of Oxford researchers receive grant to study genes that contribute to ankylosing spondylitis

A team at the University of Oxford has received a grant of £160,000 from Arthritis Research UK to study the function of the genes which contribute to people developing a painful inflammatory back condition called ankylosing spondylitis.

13 Jun 2013

ECG in your mobile!

A research scientist working at VTT Technical Research Centre of Finland has developed a user-friendly smart phone application that allows consumers to take an electrocardiogram (ECG) in the comfort of their own homes.

11 Jun 2013

$Epidural steroid injection is associated with increased spinal fracture$

Epidural steroid injection is associated with increased spinal fracture

Most aging adults will experience back pain or a spinal disorder at some time in their life. In fact, about 25.8 million visits were made to physicians' offices due to primary back problems. Treatment focuses on pain relief and is available in both non-surgical (medication or physical therapy) and surgical forms.

7 Jun 2013

Physiotherapist interaction with patient plays a significant role in pain reduction

How many times have you been to a physiotherapist where you've had more time in the waiting room than face-time with the physio? Well, according to University of Alberta physical therapy PhD grad Jorge Fuentes, how a physiotherapist interacts with a patient verbally, through eye contact, body language and listening skills is almost as important as the treatment itself.

6 Jun 2013

Gulf Coast Spine Care to use latest neck pain treatments to better meet the needs of patients

Gulf Coast Spine Care has been helping its patients treat their pain for many years, and recently the company has announced that they will be enacing a series of the latest neck pain treatments to better meet the needs of its patients.

4 Jun 2013

Gulf Coast Spine Care offers effective treatment options for sciatica

Finding relief from sciatica is imperative, and Gulf Coast Spine Care offers proven, effective treatment options for these individuals. Recently, the medical center has started offering additional treatment options for the benefit of its patients who suffer from this condition, and these treatments have provided patients with considerable improvement to their quality of life.

1 Jun 2013

Back Pain News and Research

Latest Back Pain News and Research

Spinal Restoration: Success criteria not met for primary analysis of Phase III study of Biostat System

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Cell therapies may stop or reverse pain and disability of degenerative disc disease

UC Riverside study finds that married men are less likely to die of HIV/AIDS

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

S.M. Rezaian says that the spine degrades following inadequate treatment

Weekly yoga class provides similar lower back pain relief as twice weekly classes for low-income patients

Eisai submits BELVIQ NDS with Health Canada

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Spinal infection at contaminated drug injection site detected using contrast-enhanced MRI screening

European Commission amends marketing authorisation for Celgene's REVLIMID

Xgeva receives FDA approval for treating giant cell tumor of the bone

NACC recommendations address established pain therapies and preview potential future advances

University of Oxford researchers receive grant to study genes that contribute to ankylosing spondylitis

ECG in your mobile!

Epidural steroid injection is associated with increased spinal fracture

Physiotherapist interaction with patient plays a significant role in pain reduction

Gulf Coast Spine Care to use latest neck pain treatments to better meet the needs of patients

Gulf Coast Spine Care offers effective treatment options for sciatica

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Back Pain News and Research

Latest Back Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in